Triethylenemelamine

Triethylenemelamine (TEM) is a chemical compound that belongs to the class of alkylating agents. It is primarily used in chemotherapy for its ability to interfere with the growth of cancer cells. TEM is known for its role in the treatment of various types of neoplasms, particularly in hematological malignancies.
Chemical Structure and Properties[edit]
Triethylenemelamine is a heterocyclic compound with the molecular formula C9H12N6. It is characterized by a triazine ring structure, which is a six-membered ring containing three carbon atoms and three nitrogen atoms. The presence of ethylene groups attached to the triazine ring is responsible for its alkylating activity.
Mechanism of Action[edit]
As an alkylating agent, TEM exerts its effects by forming covalent bonds with DNA, leading to cross-linking of DNA strands. This cross-linking inhibits DNA replication and transcription, ultimately resulting in cell cycle arrest and apoptosis of rapidly dividing cells. This mechanism is particularly effective against cancer cells, which have a high rate of division.
Clinical Uses[edit]
Triethylenemelamine has been used in the treatment of various cancers, including:
Its use is often limited to specific cases where other treatments have failed or are not suitable. TEM is typically administered as part of a combination chemotherapy regimen to enhance its efficacy and reduce the likelihood of resistance.
Side Effects[edit]
The use of triethylenemelamine can lead to several side effects, which are common to many alkylating agents. These include:
- Myelosuppression, leading to decreased production of blood cells
- Nausea and vomiting
- Alopecia
- Increased risk of secondary malignancies
Patients receiving TEM require careful monitoring to manage these adverse effects and to adjust dosages as necessary.
Related pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian